FDA Inspection 1047052 — Sylvia M. Lee, M.D.
The FDA completed an inspection of Sylvia M. Lee, M.D. on Mar 23, 2018 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 23, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Seattle, WA (United States)
Additional Details
Sponsor-Investigator (S-I)